Director dealings: Haleon CFO sells shares
By Iain Gilbert
Date: Wednesday 02 Jul 2025
(Sharecast News) - Haleon revealed on Wednesday that chief financial officer Dawn Allen had disposed of 83,894 ordinary shares in the London-listed consumer healthcare company.
Allen, who made the sale in two separate transactions, offloaded the shares at an average price of 375.64p each, for a total value of £315,137.75p.
As of 1540 BST, Haleon shares were down 0.53% at 373.60p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Faron Pharmaceuticals Oy (di) (FARN)
Director name: Pätsi,Tuomo
Amount purchased: 21,500 @ 2.43
Value: 47,164.41
Triad Group (TRD)
Director name: Lander,Alison
Amount purchased: 6,722 @ 297.50p
Value: £19,997.95
Utilico Emerging Markets Ltd (di) (UEM)
Director name: Wells ,Nadya
Amount purchased: 3,290 @ 244.00p
Value: £8,027.60
Stelrad Group (SRAD)
Director name: Ker,Katherine Innes
Amount purchased: 2,515 @ 163.00p
Value: £4,099.45
Top Director Sells
Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 64,329 @ 375.64p
Value: £241,644.17
Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 19,565 @ 375.64p
Value: £73,493.58
Rs Group (RS1)
Director name: Ringrose ,Kate
Amount sold: 6,143 @ 580.50p
Value: £35,660.11
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN